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Abstract
Background: Risk prediction techniques commonly used in liver surgery include the American Society of
Anesthesiologists (ASA) grading, Charlson Comorbidity Index (CCI) and cardiopulmonary exercise tests (CPET). This
study compares the utility of these techniques along with the number of segments resected as predictive tools in
liver surgery.
Methods: A review of a unit database of patients undergoing liver resection between February 2008 and January
2015 was undertaken. Patient demographics, ASA, CCI and CPET variables were recorded along with resection size.
Clavien-Dindo grade III–V complications were used as a composite outcome in analyses. Association between
predictive variables and outcome was assessed by univariate and multivariate techniques.
Results: One hundred and seventy-two resections in 168 patients were identified. Grade III–V complications
occurred after 42 (24.4%) liver resections. In univariate analysis of CPET variables, ventilatory equivalents for CO2
(VEqCO2) was associated with outcome. CCI score, but not ASA grade, was also associated with outcome. In
multivariate analysis, the odds ratio of developing grade III–V complications for incremental increases in VEqCO2,
CCI and number of liver segments resected were 1.09, 1.49 and 2.94, respectively.
Conclusions: Of the techniques evaluated, resection size provides the simplest and most discriminating predictor
of significant complications following liver surgery.
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Background
Despite the technical advances, liver resection remains po-
tentially dangerous and is associated with a morbidity rate
of 18.2–32.4% (Ulyett et al. 2015; Wiggans et al. 2014;
Poon et al. 2004) and mortality rate of 1.4–5.3% (Nygard
et al. 2012; Belghiti et al. 2000; Dimick et al. 2004).
Preoperative estimation of risk allows counselling of pa-
tients regarding treatment options and helps in operative
planning. A number of techniques are commonly used
preoperatively to estimate risk including the American
Society of Anesthesiology (ASA) grade, Charlson Comor-
bidity Index (CCI) and Cardiopulmonary Exercise Tests
(CPET). The ASA grading system is a subjective assess-
ment of the degree of systemic disease made at the time
of surgery (Saklad 1941). CCI is a 22-point scoring matrix
based on comorbid diagnoses (Charlson et al. 1987),
which was originally designed to predict long-term sur-
vival in an unselected population but has also been
shown to be of value in predicting outcome after sur-
gery (Backemar et al. 2015; Schmolders et al. 2015).
CPET provides an objective measurement of cardiore-
spiratory fitness, where the volume of oxygen con-
sumption at peak (VO2 peak) and at anaerobic threshold
(AT), ventilatory efficiency in the elimination of carbon
dioxide (CO2) (VEeqCO2), heart rate (HR) and oxygen
(O2) pulse (a surrogate measure of cardiac output) are
measured. This technique was initially used to predict
mortality in patients undergoing a range of abdominal
procedures (Older et al. 1993) and has been shown to
be of value in predicting outcomes in patients undergo-
ing pancreatic (Chandrabalan et al. 2013) and vascular
(Thompson et al. 2011) surgery.
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Data on the use of these tools in the context of liver
surgery is scarce. The ASA grade has been shown to in-
fluence the development of postoperative complications
after liver resection (Belghiti et al. 2000), and CCI has
been assessed in the prediction of short-term outcomes
(Schroeder et al. 2006). Data on the use of CPET before
liver surgery is conflicting, with one study showing a
useful correlation with complications (Junejo et al. 2012)
and another showing only minimal association (Dunne
et al. 2014). None of the tools takes into account the
extent of the proposed operation, and no comparison
between the techniques has been undertaken.
The aim of this study is to determine the relative value
of these risk prediction tools in patients undergoing liver
surgery and also to assess their value compared to risk
prediction based on the extent of the surgical procedure
undertaken.
Methods
A review of a prospectively maintained database of all pa-
tients undergoing resection of parenchymal liver lesions
between February 2008 and January 2015 was undertaken.
Follow up was completed in June 2015. The primary
endpoint was development of Clavien-Dindo (CD) grade
III–V complications.
To reduce heterogeneity of the study population,
patients undergoing synchronous bowel resection or
surgery for obstructing lesions of the proximal hepatic
duct or in the presence of liver cirrhosis were excluded, as
surgery in these situations is associated with higher risk
(Wiggans et al. 2014; Belghiti et al. 2000; Das et al. 2001).
Liver resection was undertaken using Cavitron Ultrasonic
Surgical Aspirator (CUSA). General anaesthetic was ad-
ministered by specialist liver anaesthetists. Low central
venous pressures (CVP) were maintained although in-
vasive CVP monitoring was not undertaken. The extent
of liver resection was described according to the Brisbane
Classification (Pang 2002). Radiofrequency ablation (RFA)
was used where major liver resections were performed
leaving a residual contralateral disease. Where sub-
segmental resections were undertaken, these were
rounded up to the nearest integer in analyses. Postop-
eratively, all patients undergoing major resection were
cared for in a critical care unit. Retrieved data include
age, gender, indication for surgery and use of pre-
operative chemotherapy. ASA grade was determined
at the time of surgery by the responsible anaesthetist,
and CCI was calculated postoperatively from clinical
records. The use of perioperative blood transfusion
was also recorded.
CPET was introduced as a preoperative assessment tool
in February 2008 and was initially available at the discre-
tion of referring consultants for patients considered to be
at higher risk of surgical complications. After November
2013, CPET has been undertaken in the majority of pa-
tients. CPET was undertaken using a cycle ergometer
(nSpire™ Zan® 600, Colorado, USA, or MGC Diagnos-
tics®, MN, USA). The protocol consists of 2 mins of
rest, 1 min of cycling without resistance, and then a
ramped protocol of between 10 and 25 watts/min.
CPET variables measured included VO2 peak, anaerobic
threshold (AT), O2 pulse, relative O2 pulse, resting
(rHR) and peak heart rate (pHR) and ventilatory equiv-
alents for CO2 (VEqCO2). AT was calculated using the
V-slope method and VO2 peak was averaged over the
last 30 s of the test. CPET were undertaken and inter-
preted by three specialist liver anaesthetists. In patients
where AT was not achieved, a nominal low value of
8 ml/kg/min was assigned as this group have been
shown to have poor outcomes (Lai et al. 2013; Challand
et al. 2012).
Postsurgical outcomes occurring within 30 days of
surgery were classified according to the CD system
(Dindo et al. 2004). Broadly, grade I–II complications
include minor variations in the patient pathway includ-
ing the use of anti-emetics and antibiotics, grade III
complications require postoperative intervention (com-
monly for bile leaks), grade IV complications are deter-
mined by organ failure and grade V complication is death.
In this study, grade III–V complications were used as a
composite outcome of significant adverse postoperative
events. Patients may develop complications in more than
one grade, particularly as grade III and IV complications
may have different aetiology. Liver failure was classified
according to the International Study Group for Liver
Surgery consensus definition of post-hepatectomy liver
failure (PHLF) (Rahbari et al. 2011) and renal failure
according to the RIFLE scoring system (Bellomo et al.
2004). For the purposes of this study, heart failure was
defined as the requirement for inotropic medication to
treat hypotension of suspected cardiac cause, after re-
moval of epidural catheter. Respiratory failure was defined
as a return to critical care unit for respiratory support.
Statistical analyses were carried out using chi-square
and Mann-Whitney U tests for categorical and continuous
data, respectively. Binary logistic regression was used to
assess the effect of risk factors on outcome. Repeat resec-
tions in individual patients were analysed separately where
separate CPET were performed.
Confirmation was obtained from the South-West Health
Research Authority that Research Ethics Committee re-
view was not required because patient data were collected
prospectively as a normal part of hospital care, and all
data were anonymised. No patient consent was required
for this study. This study was registered with the Research
Registry (unique identification 464) (Research Registry)
and conforms with the STROBE guidelines (von Elm et al.
2008).
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Results
Details of patients selected for the study are shown in
Fig. 1. Nine (5%) patients had repeat resections. Patient
and operative characteristics, CPET parameters and
ASA and CCI scores are shown in Table 1. VEqCO2 re-
sults were unavailable in five patients. Intraoperative
RFA was used in addition to resection in 11 patients and
portal vein embolization prior to resection in three pa-
tients. Laparoscopic resection was performed on 32
(18.6%) occasions.
A surgeon estimated that the intraoperative blood loss
was less than 500 ml in 81 (47%) and more than
1000 ml in 31 (18%) resections. Forty-four patients re-
quired a blood transfusion intraoperatively with a me-
dian transfusion of 2 units (1–18) for those transfused.
Clavien-Dindo grade III to V complications occurred fol-
lowing 42 (24%) of 172 resections (Table 2). Eleven pa-
tients suffered both III and IV/V complications. One
patient developed heart failure secondary to cardiac
arrhythmia requiring cardiac pacing. There were no
cases of postoperative respiratory failure. The proportion
of patients suffering grade III–V complications in the se-
lective and non-selective CPET periods was similar (22
and 27%, respectively).
Demographic details, ASA, CCI, use of pre-operative
chemotherapy, CPET variables and the number of liver
segments resected in patient groups with and without
significant postoperative complications are shown in
Table 3. In univariate analysis CCI score, but not ASA
grade, was associated with grade III–V complications
(P = 0.02). Of the CPET variables, VEeqCO2 was associ-
ated with the development of grade III–V complications
(P = 0.005). AT was not detectable in three patients
due to very limited exercise tolerance, and none of
whom suffered grade III–V complications. The num-
ber of liver segments resected was strongly associated
with outcome (Fig. 2). The use of preoperative
chemotherapy was not associated with postoperative
complications.
Multivariate analysis of predictive scores and the ex-
tent of liver resection shows that the extent of resection,
VEqCO2 and CCI are independently associated with the
development of grade III–V complications (Table 4).
ASA grade was not associated with outcome. The stron-
gest association with complications was shown to be
with the extent of liver resection, where each extra seg-
ment of liver resected increased the odds of developing
CD grade III–V complications by a factor of 2.94 (1.86–
4.66). The greatest range of predictive values (17–50)
was noted for VEqCO2, where an incremental increase
of 1.09 was noted in the OR of developing grade III–V
complications.
Fig. 1 Study population derived from 640 patients considered for liver resection between February 2008 and January 2015
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Discussion
The main finding of this study is the very significant
association between postoperative complications in liver
surgery and the extent of the liver resection undertaken.
There is a weaker association between postoperative
complications and risk scores formulated by assessment
of recorded comorbidity (CCI) and CPET parameters.
Subjective assessment of a patient’s fitness at the time of
surgery by ASA score is not predictive of postoperative
complications.
The scoring systems under assessment in this study were
chosen because they assess risk by different techniques.
CPET is an objective measure of cardiovascular fitness,
CCI scores are derived from recorded comorbidity, ASA
grade is a subjective assessment of overall health and the
number of liver segments resected provides a simple meas-
ure of operative extent. Assessment of the techniques in
parallel allows a comparison of their relative utility.
The role of CPET in liver surgery is yet to be estab-
lished, with conflicting outcomes from the two published
studies investigating the technique (Junejo et al. 2012;
Dunne et al. 2014). CPET is useful in surgery where
cardiorespiratory complications form a major part of ad-
verse outcomes, such as vascular (Thompson et al. 2011;
Elkouri et al. 2004) and cardiothoracic (Van Diepen et al.
2014) surgery. As the main cause of morbidity and death
after liver surgery is liver failure (Poon et al. 2004; Belghiti
et al. 2000; Jarnagin et al. 2002), the degree of cardiovascu-
lar fitness is likely to have a weaker association with
outcome. In our series, significant cardiovascular compli-
cations were rare, occurring in only two patients. Also, pa-
tients undergoing liver resection may be a selected group
with better physical function, as many will have previously
undergone, and recovered from, primary colorectal sur-
gery. AT was originally shown to be useful in predicting
mortality in a large, unselected population undergoing a
range of elective abdominal procedures including vascular
surgery, in which 24% of patients had evidence of pre-
existing cardiovascular disease (Older et al. 1993), and
mortality in this context is more likely to be related to
cardiovascular health.
Table 1 Baseline patient characteristics
Age (median [range]) 69 (22–90) CPET parameters
Gender (%)







134 (77.9) VO2 peak
(ml/kg/min, [range])
18.9 (6.4–35.5)
Hepatoma 12 (7) 11.8 (5–25.3)
Neuroendocrine
tumour




I 8 (4.7) 14.9 (7.8–26.6)












Yes 62 (36) 29.6 (17.1–49.9)
No 94 (54.7)












Demographic and operative characteristics of 172 liver resections in 168
patients who had preoperative CPET
RFA radiofrequency ablation
Table 2 Summary of complications after liver resection
Grade III complications (%) 15 (8.6)
• Bile leak requiring ERCP 3 (1.7)
• Bile leak requiring drain 4 (2.3)
• Infected collection requiring drain 1 (0.6)
• Further surgery required 2 (1.1)
• Open drainage of collection following colonic injury,
• Laparotomy undertaken for ileus
• Pneumothorax requiring drain 1 (0.6)
• Cardiac pacing 1 (0.6)
• Ascites requiring drain 1 (0.6)
• Pleural effusion requiring drain 1 (0.6)
• Gastric burn secondary to radiofrequency ablation 1 (0.6)
Grade IV and V complications (%) 37 (21.3)
• Liver failure alone 24 (13.8)
• Renal failure alone 6 (3.4)
• Liver and renal failure 6 (3.4)
• Heart failure 2 (1.1)
• Death 2 (1.1)
Summary of Clavien-Dindo grade III–V postoperative complications following
172 liver resections in 168 patients. Some patients suffered more than
one complication
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Of the CPET parameters under study, VEqCO2 was
shown to be predictive of postoperative complications, in
keeping with earlier findings (Junejo et al. 2012). Although
the incremental OR for predicting CD grade III–V compli-
cations is low (1.09), this effect is noted over a large range
of values (17–50). Despite other studies demonstrating
the value of AT in the prediction of outcomes after liver
resection (Dunne et al. 2014), this parameter was not
shown to be of value in this series, although many of the
CPET variables are mathematically related, and the differ-
ence in predictive value between them may be less than is
apparent in a multivariate analysis. In a similar manner to
CCI, the median VEqCO2 was very similar between
groups with CD grade 0–II and III–V complications (29.1
vs 31.7) with significant overlap in range, and this may
limit the usefulness of this test. ASA was not shown to
Table 3 Comparison of potential risk factors for developing complications
Variable (median) CD 0–II (n = 130) CD III–V (n = 42) P value
Age (range) 69 (22–90) 70 (49–88) 0.47
Gender (%) 0.057
Male 85 (65.4) 34 (81)
Female 45 (34.6) 8 (19)
ASA (%) 0.187
I–II 80 (61.5) 21 (50)
III–IV 50 (38.5) 21 (50)
CCI (range) 4 (0–7) 5 (1–9) 0.021
Preoperative chemotherapy (%) 0.85
Yes 46 (35.4) 16 (38.1)
No 71 (54.6) 23 (54.8)
Unknown 13 (10) 3 (7.1)
Number of segments resected (range) 3 (1–6) 4 (3–6) < 0.001
VO2 at AT (ml/kg/min, [range]) 12.8 (6.4–22.9) 12.5 (5.6–23.1) 0.84
VO2 peak (ml/kg/min, [range]) 18.8 (6.4–35.5) 19.2 (11.8–30.8) 0.65
Oxygen pulse (ml/beat, [range]) 11 (5–20.5) 12.3 (5–25.3) 0.39
Relative oxygen pulse (100 ml/beat/kg, [range]) 15 (7.8–26.6) 14.9 (10–24.5) 0.52
Resting heart rate (beats/min, [range]) 74 (39–115) 80 (43–119) 0.54
Peak heart rate (beats/min, [range]) 131.5 (79–180) 133.5 (85–172) 0.89
VEeqCO2 at AT (range) 29.1 (17.1–49.9) 31.7 (24.4–46.2) 0.005
Univariate analysis of association of age, gender, diagnosis, ASA grade, CCI, preoperative chemotherapy, extent of resection and CPET values with Clavien-Dindo
0–II and III–V complications following 172 liver resections
Fig. 2 Association of a extent of liver resection, b CCI score and c VEqCO2 with the risk of developing Clavien-Dindo grade III–V complications
following 172 liver resections. N.B. The number of liver segments resected was analysed as a discrete variable, whereas the CCI and VEqCO2 were
analysed as continuous variables
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predict outcome in multivariate analysis compared with
the other measures. ASA is known to be a highly subject-
ive tool, with significant inter-observer variation (Mak et
al. 2002; Ranta et al. 1997). In practice, this is also too
blunt a tool to be of value, as 95% of patients have ASA
score of II or III.
The CCI is a well-researched measure used to weight
outcomes in cancer surgery (Dobbins et al. 2015). The
tool has also been used in registry data when comparing
outcomes between individual hospitals (Dobbins et al.
2015) and clinicians (Ugolini and Nobilio 2004). Its role
in predicting specific surgical complications is variable.
It has not been shown to be associated with complica-
tions in gynaecologic or colorectal surgery (Suidan et al.
2015; Krarup et al. 2015), but is associated with outcome
in orthopaedic surgery (Schmolders et al. 2015). While
CCI is associated with complications in this study, it is
less predictive of outcome over the range of measured
values than either the number of liver segments resected
or VEqCO2 (Fig. 2). Although CCI provides a simple
measure that can be easily calculated with knowledge of
a patient’s medical history, the median score of patients
suffering grade III–V complications is only one point
higher than those with grade 0–II complications, with a
large overlap in the score range which limits the useful-
ness of the technique. Also, the CCI system records co-
morbidity rarely relevant in the context of elective liver
surgery, including AIDS and lymphoma, while other more
common potential risk factors, such as extremes of BMI
(Vigano et al. 2011; Balzan et al. 2010) and NAFLD
(Wakai et al. 2011), are not included.
The factor with the greatest predictive value for out-
come in this analysis is the extent of the liver resection
undertaken, which may be expected as liver failure due to
insufficient liver volume is the major cause of death after
liver surgery (Wiggans et al. 2013). The high odds ratio of
2.94 in the prediction of grade III–V complications for
increasing number of resected segments make this a factor
of high clinical relevance and easily utilised, as the extent
of liver resection to be undertaken is usually known pre-
operatively. Of note, the increased risk of liver resection
with increasing number of resected segments is non-
linear, with the largest absolute increase in risk being
experienced by patients undergoing resection of five and
six liver segments.
Each of the three techniques shown to be of value has
very wide confidence intervals in the prediction of out-
come (Fig. 2). The potential risk faced by patients under-
going liver surgery is affected by all of the factors under
study (comorbidity, physical functioning and extent of
liver resection), and each of the tests used individually
therefore will be limited in their predictive value. Other
factors are also likely to influence operative risk, particu-
larly the presence of a coexisting liver disease. A useful
area of further study would be to develop a compound
risk scoring system based on all these factors.
The study may be subject to bias due to patient selec-
tion. Throughout the series, CPET has been undertaken
on patients perceived to be less healthy, which accounts
for the male predominance of the population under study.
It is unlikely however that CPET parameters would be
more predictive of complications in a healthier population.
A potential limitation of this study is the degree of con-
founding caused by prior awareness of CPET results by
clinicians, as it is possible that patients with low levels of
fitness were treated differently. Preoperative medication
which may affect CPET results has not been recorded.
However, in undertaking CPET, it is important to estimate
functional parameters as they would be at the time of sur-
gery, including the influence of medication.
Conclusions
This study represents a large case-series, which attempts
to answer the question of how best to assess risk in pa-
tients undergoing liver resection. The simplest factor to
consider is the extent of the planned liver resection. CCI
and CPET parameters may be useful discriminators for
potential risk in patients undergoing the same resection
type and may also contribute to decision-making in pa-
tients who require extended liver resections.
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Table 4 Comparison of risk assessment techniques
OR 95% CI P value Range of
predictive
values
ASA grade 0.85 0.37–1.94 0.7 1–4
CCI score 1.49 1.09–2.04 0.01 0–9
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Multivariate analysis of risk assessment techniques in the prediction of CD
grade III–V complications compared with grade 0–II complications following
172 liver resections
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